Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Amortization of Deferred Charges (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Amortization of Deferred Charges for 4 consecutive years, with $654000.0 as the latest value for Q1 2020.

  • Quarterly Amortization of Deferred Charges rose 360.56% to $654000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Mar 2020, up 91.18% year-over-year, with the annual reading at $1.7 million for FY2019, 46.25% up from the prior year.
  • Amortization of Deferred Charges for Q1 2020 was $654000.0 at Forte Biosciences, up from $57000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.4 million in Q3 2019, with the low at $57000.0 in Q4 2019.
  • Average Amortization of Deferred Charges over 4 years is $315615.4, with a median of $147000.0 recorded in 2017.
  • Peak annual rise in Amortization of Deferred Charges hit 847.55% in 2019, while the deepest fall reached 80.17% in 2019.
  • Over 4 years, Amortization of Deferred Charges stood at $149000.0 in 2017, then dropped by 2.68% to $145000.0 in 2018, then tumbled by 60.69% to $57000.0 in 2019, then soared by 1047.37% to $654000.0 in 2020.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $654000.0, $57000.0, and $1.4 million for Q1 2020, Q4 2019, and Q3 2019 respectively.